For example, a specific GLP1R variant may correlate with either stronger or more modest appetite suppression in some individuals, but genetics is only one factor
SURMOUNT-MAINTAIN randomized patients who had lost weight on the maximum dose of tirzepatide to either continue at full dose of 10 or 15 mg, reduce to 5 mg, or switch to placebo for an additional year
Many people still prefer a diet and exercise-first approach Nearly a quarter ( 24.41% ) of respondents said they preferred to focus on changes to their diet and levels of exercise rather than starting medication
On the other hand, cardiovascular tissues react to GLP-1 via activated survival pathways, indicating possible protective benefits
MarketScan data for this article represents commercial claims incurred January 2020 December 2024
Start here to get 15% off your first order, they'll send you a link to their free, HIPAA compliant, secure patient portal